Free Trial

Kyverna Therapeutics (KYTX) Institutional Ownership

Kyverna Therapeutics logo
$2.30 -0.01 (-0.43%)
As of 11:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)

Current
Institutional Ownership
Percentage
18.08%
Number of
Institutional Buyers
(last 12 months)
61
Total
Institutional Inflows
(last 12 months)
$230.39M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$8.07M
Get KYTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2025Peapod Lane Capital LLC396,221$765K0.9%N/A0.917%
4/29/2025 Bank of New York Mellon Corp48,784$94K0.0%+22.2%0.113%
4/8/2025 Rhumbline Advisers31,614$61K0.0%+22.0%0.073%
3/24/2025Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636%
2/19/2025Public Employees Retirement System of Ohio33,434$125K0.0%N/A0.077%
2/17/2025Squarepoint Ops LLC11,488$43K0.0%N/A0.027%
2/17/2025Two Sigma Advisers LP80,290$300K0.0%+375.1%0.186%
2/17/2025Two Sigma Investments LP181,654$679K0.0%+47.9%0.421%
2/17/2025Sphera Funds Management LTD.118,758$444K0.1%-52.2%0.275%
2/17/2025Millennium Management LLC746,521$2.79M0.0%-40.4%1.729%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,288$53K0.0%+53.7%0.033%
2/17/2025Integral Health Asset Management LLC350,000$1.31M0.1%+75.0%0.811%
2/17/2025Jacobs Levy Equity Management Inc.461,959$1.73M0.0%+2,225.0%1.070%
2/17/2025Corton Capital Inc.12,099$45K0.0%N/A0.028%
2/17/2025Cubist Systematic Strategies LLC52,361$196K0.0%-24.1%0.121%
2/17/2025Bridgeway Capital Management LLC80,000$299K0.0%N/A0.185%
2/17/2025Bank of America Corp DE21,788$81K0.0%+41.6%0.050%
2/17/2025BNP Paribas Financial Markets44,983$168K0.0%+65.4%0.104%
2/17/2025Ameriprise Financial Inc.190,383$712K0.0%+55.1%0.441%
2/14/2025Northern Trust Corp195,694$732K0.0%+46.1%0.453%
2/14/2025Price T Rowe Associates Inc. MD593,688$2.22M0.0%-5.5%1.375%
2/14/2025Stifel Financial Corp39,342$147K0.0%N/A0.091%
2/14/2025Gilead Sciences Inc.4,126,119$15.43M1.0%N/A9.558%
2/13/2025Marshall Wace LLP15,241$57K0.0%-52.7%0.035%
2/13/2025XTX Topco Ltd43,949$164K0.0%-16.8%0.102%
2/13/2025Barclays PLC89,586$336K0.0%+27.7%0.208%
2/13/2025Renaissance Technologies LLC44,700$167K0.0%N/A0.104%
2/13/2025Wells Fargo & Company MN179,012$670K0.0%+16.4%0.415%
2/12/2025Geode Capital Management LLC539,682$2.02M0.0%+21.7%1.250%
2/12/2025Franklin Resources Inc.692,028$2.59M0.0%-26.1%1.603%
2/12/2025Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636%
2/12/2025Norges Bank40,000$150K0.0%N/A0.093%
2/12/2025JPMorgan Chase & Co.2,166,437$8.10M0.0%-9.3%5.018%
2/11/2025Corebridge Financial Inc.12,811$48K0.0%+42.3%0.030%
2/6/2025Charles Schwab Investment Management Inc.169,780$635K0.0%+1.9%0.393%
2/4/2025 Bank of New York Mellon Corp39,933$149K0.0%-7.7%0.093%
1/30/2025 Rhumbline Advisers25,920$97K0.0%+31.1%0.060%
1/24/2025China Universal Asset Management Co. Ltd.9,154$34K0.0%N/A0.021%
1/15/2025 Kera Capital Partners Inc.376,131$1.41M0.4%N/A0.871%
12/26/2024JPMorgan Chase & Co.2,387,352$11.67M0.0%+15.8%5.530%
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
11/27/2024Franklin Resources Inc.936,961$4.58M0.0%+13.8%2.170%
11/19/2024Barclays PLC70,167$343K0.0%+21.5%0.163%
11/16/2024Geode Capital Management LLC443,312$2.17M0.0%+19.0%1.027%
11/15/2024Barclays PLC70,167$343K0.0%+21.5%0.163%
11/15/2024XTX Topco Ltd52,792$258K0.0%-36.6%0.122%
11/15/2024Jane Street Group LLC39,193$192K0.0%+78.3%0.091%
11/15/2024Wellington Management Group LLP235,123$1.15M0.0%-67.0%0.545%
11/15/2024Sphera Funds Management LTD.248,651$1.22M0.2%+5.3%0.576%
11/15/2024State Street Corp326,192$1.60M0.0%+3.2%0.756%
11/15/2024Point72 Asset Management L.P.34,482$169K0.0%N/A0.080%
11/15/2024Jacobs Levy Equity Management Inc.19,869$97K0.0%N/A0.046%
11/14/2024Verition Fund Management LLC44,626$218K0.0%N/A0.103%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC101,900$498K0.0%-11.7%0.236%
11/13/2024BNP Paribas Financial Markets27,197$133K0.0%+2,166.4%0.063%
11/13/2024FMR LLC6,692$33K0.0%N/A0.016%
11/12/2024Charles Schwab Investment Management Inc.166,635$815K0.0%+33.2%0.386%
10/24/2024Novo Holdings A S1,850,000$9.05M0.4%+5.7%4.291%
10/11/2024Creative Planning11,028$54K0.0%N/A0.026%
8/26/2024Teachers Retirement System of The State of Kentucky21,410$161K0.0%+69.7%0.050%
8/20/2024Novo Holdings A S1,750,000$13.13M0.7%+150.0%4.059%
8/15/2024The Manufacturers Life Insurance Company37,794$283K0.0%+32.6%0.088%
8/15/2024Millennium Management LLC923,082$6.92M0.0%+32.8%2.141%
8/15/2024MBB Public Markets I LLC410,191$3.08M0.1%N/A0.951%
8/15/2024Deerfield Management Company L.P. Series C1,983,000$14.87M0.2%+35.6%4.599%
8/15/2024Affinity Asset Advisors LLC200,000$1.50M0.2%N/A0.464%
8/14/2024Great Point Partners LLC499,152$3.74M0.7%+232.8%1.158%
8/14/2024Marshall Wace LLP10,400$78K0.0%-93.3%0.024%
8/13/2024Skandinaviska Enskilda Banken AB publ26,195$196K0.0%+55.8%0.061%
8/12/2024XTX Topco Ltd83,286$625K0.1%N/A0.193%
8/12/2024E Fund Management Co. Ltd.189,432$1.42M0.1%N/A0.439%
8/10/2024Sofinnova Investments Inc.47,850$359K0.0%+378.5%0.111%
8/8/2024Federated Hermes Inc.16,000$120K0.0%N/A0.037%
8/3/2024TD Asset Management Inc90,242$677K0.0%N/A0.209%
8/1/2024 Rhumbline Advisers20,007$150K0.0%N/A0.046%
7/26/2024 Bank of New York Mellon Corp55,790$418K0.0%N/A0.129%
6/4/2024DekaBank Deutsche Girozentrale7,500$181K0.0%N/A0.017%
5/28/2024Teachers Retirement System of The State of Kentucky12,614$313K0.0%N/A0.029%
5/17/2024Artal Group S.A.200,000$4.97M0.1%N/A0.464%
5/16/2024Janus Henderson Group PLC606,500$15.04M0.0%N/A1.407%
5/16/2024Bain Capital Life Sciences Investors LLC3,163,868$78.59M6.3%N/A7.338%
5/16/2024Blackstone Inc.100,000$2.48M0.0%N/A0.232%
5/15/2024Price T Rowe Associates Inc. MD929,634$23.09M0.0%N/A2.156%
5/15/2024Avoro Capital Advisors LLC475,000$11.80M0.1%N/A1.102%
5/14/2024StemPoint Capital LP41,000$1.02M0.3%N/A0.095%
5/10/2024Vanguard Group Inc.264,215$6.56M0.0%N/A0.613%
5/2/2024Jennison Associates LLC1,398,659$34.74M0.0%N/A3.244%
(Data available from 1/1/2016 forward)

KYTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of KYTX shares?

During the previous two years, 64 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($78.59M), Jennison Associates LLC ($34.74M), Gilead Sciences Inc. ($15.43M), Janus Henderson Group PLC ($15.04M), Deerfield Management Company L.P. Series C ($14.87M), Avoro Capital Advisors LLC ($11.80M), and Novo Holdings A S ($9.05M).Learn more on KYTX's institutional investors.

What percentage of Kyverna Therapeutics stock is owned by institutional investors?

18.08% of Kyverna Therapeutics stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings.

Which institutional investors have been buying Kyverna Therapeutics stock?

Of the 61 institutional investors that purchased Kyverna Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gilead Sciences Inc. ($4.13M), Bain Capital Life Sciences Investors LLC ($3.16M), Jennison Associates LLC ($1.40M), Novo Holdings A S ($1.15M), Price T Rowe Associates Inc. MD ($929.63K), Janus Henderson Group PLC ($606.50K), and Deerfield Management Company L.P. Series C ($520.66K).

How much institutional buying is happening at Kyverna Therapeutics?

Institutional investors have bought a total of 17,625,728 shares in the last 24 months. This purchase volume represents approximately $230.39M in transactions.

Which Kyverna Therapeutics major shareholders have been selling company stock?

Of the 11 institutional investors that sold Kyverna Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($507.04K), Wellington Management Group LLP ($478.28K), Franklin Resources Inc. ($244.93K), JPMorgan Chase & Co. ($220.92K), Marshall Wace LLP ($162.34K), Sphera Funds Management LTD. ($129.89K), and XTX Topco Ltd ($39.34K).

How much institutional selling is happening at Kyverna Therapeutics?

Institutional investors have sold a total of 1,850,656 shares in the last 24 months. This volume of shares sold represents approximately $8.07M in transactions.



This page (NASDAQ:KYTX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners